Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome

ISSN： 1460-2369

Source： Human Reproduction Update, Vol.11, Iss.4, 2005-07, pp. : 375-390

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of placebo‐controlled insulin‐sensitizing drugs on hormonal parameters in polycystic ovary syndrome patients: A network meta‐analysis

JOURNAL OF CELLULAR BIOCHEMISTRY, Vol. 119, Iss. 3, 2018-03 ,pp. : 2501-2511

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metformin in therapy nave patients with polycystic ovary syndrome

By Palomba Stefano Falbo Angela

Human Reproduction Update, Vol. 14, Iss. 2, 2008-01 ,pp. : 193-193

Oxford University Press

Access to resources Recommend Favorite

Exercise therapy in polycystic ovary syndrome: a systematic review

By Harrison Cheryce L. Lombard Catherine B. Moran Lisa J. Teede Helena J.

Human Reproduction Update, Vol. 17, Iss. 2, 2011-10 ,pp. : 171-183

Oxford University Press

Access to resources Recommend Favorite

Use of metformin for women with polycystic ovary syndrome †

By Tang Thomas Balen Adam H.

Human Reproduction Update, Vol. 19, Iss. 1, 2013-01 ,pp. : 1-1

Oxford University Press

Access to resources Recommend Favorite

A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome

By Boomsma C.M. Eijkemans M.J.C. Hughes E.G. Visser G.H.A. Fauser B.C.J.M. Macklon N.S.

Human Reproduction Update, Vol. 12, Iss. 6, 2006-11 ,pp. : 673-683

Oxford University Press

Access to resources Recommend Favorite